Company Overview and News

3
More Upside In Small Caps

2018-06-14 seekingalpha
In this article, we discuss the reasoning for the outperformance of small cap stocks versus large cap stocks and why small cap stocks have more room to grow.
MTSI NVEE CTRL NMIH

122
NAPCO Security: Waiting For Godot Or Multiple Inflection Points?

2018-06-11 seekingalpha
The NAPCO Security story is an interesting one. I have researched all major access control companies and NAPCO is by far the most unique story.
AMZN GOOGL ALLE CTRL NSSC GOOG

10
CTRL / Control4 Corp SD

2018-05-30 sec.gov
UNITED STATES
CTRL

40
Game Plan For The Week - Cramer's Mad Money (5/11/18)

2018-05-14 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday, May 11.
CHOO JWN BUD NICE PLD DCT CTRL M JYMHF

2
CTRL / Control4 Corp 10-Q (Quarterly Report)

2018-05-04 sec.gov
ctrl_Current Folio_10Q Table of Contents <
CTRL

3
3 Stocks Rallying over 10% on Strong Q1 Results

2018-05-04 marketrealist
Three stocks are moving higher by over 10% at the opening of today’s trading session on the heels of their first-quarter earnings releases. Let’s take a quick look at each stock.
CTRL LYV WING

6
Control4 Corporation's (CTRL) CEO Martin Plaehn on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Good day, and welcome to the Control4 First Quarter Fiscal Year 2018 Earnings Conference Call. Today's call is being recorded.
DISH GNCMA GNCMB SU CTRL GLIBA

3
CTRL / Control4 Corp 8-K (Current Report)

2018-05-03 sec.gov
UNITED STATES
CTRL

17
Control4 (CTRL) is Oversold: Can It Recover?

2018-04-09 zacks
Control4 Corporation (CTRL - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at CTRL given that, according to its RSI reading of 28.87, it is now in oversold territory.
SNSS CTRL

2
CTRL / Control4 Corp null

2018-03-21 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CTRL

2
CTRL / Control4 Corp null

2018-03-21 sec.gov
fp0032020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CTRL

4
Cramer Remix: The magic ingredient sending Netflix to new highs

2018-03-16 cnbc
After a tech-filled week at CNBC's 1Market in San Francisco, Jim Cramer started thinking about one of his favorite high-growth names in the space: the stock of Netflix.
NEWR RUN CTRL UTX

3
Cramer's lightning round: I've got too many headaches to buy a REIT

2018-03-16 cnbc
Welltower: "Real estate investment trust. We do not need that right now. I've got enough headaches."
RUN CTRL

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to CTRL / Control4 Corp on message board site Silicon Investor.

Control 4
CUSIP: 21240D107